DAVENPORT & Co LLC Acquires 63,447 Shares of Healthpeak Properties, Inc. $DOC

DAVENPORT & Co LLC lifted its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 10.1% in the third quarter, Holdings Channel reports. The fund owned 688,841 shares of the real estate investment trust’s stock after purchasing an additional 63,447 shares during the quarter. DAVENPORT & Co LLC’s holdings in Healthpeak Properties were worth $13,191,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State Street Corp raised its position in Healthpeak Properties by 0.9% during the second quarter. State Street Corp now owns 48,602,649 shares of the real estate investment trust’s stock valued at $851,032,000 after purchasing an additional 442,481 shares during the period. JPMorgan Chase & Co. increased its position in shares of Healthpeak Properties by 21.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 20,024,030 shares of the real estate investment trust’s stock valued at $350,621,000 after purchasing an additional 3,540,367 shares during the last quarter. Geode Capital Management LLC raised its holdings in Healthpeak Properties by 1.0% during the 2nd quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock valued at $332,625,000 after buying an additional 197,540 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Healthpeak Properties by 2.8% in the second quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock worth $184,208,000 after buying an additional 282,155 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock worth $186,405,000 after buying an additional 7,872,150 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 1.5%

Shares of DOC opened at $16.01 on Thursday. The firm has a market capitalization of $11.13 billion, a price-to-earnings ratio of -320.14, a PEG ratio of 4.00 and a beta of 1.11. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.22 and a quick ratio of 1.22. Healthpeak Properties, Inc. has a 1-year low of $15.71 and a 1-year high of $21.28. The company has a 50-day moving average of $17.52 and a 200 day moving average of $17.79.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The business had revenue of $705.87 million for the quarter, compared to analyst estimates of $681.65 million. During the same period last year, the company posted $0.45 earnings per share. The company’s quarterly revenue was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) dividend on an annualized basis and a yield of 7.6%. Healthpeak Properties’s payout ratio is -2,440.00%.

Analysts Set New Price Targets

DOC has been the topic of a number of analyst reports. Wells Fargo & Company boosted their price objective on shares of Healthpeak Properties from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th. Robert W. Baird dropped their price target on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research note on Wednesday, November 12th. Jefferies Financial Group lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $21.00 to $17.00 in a research report on Monday, December 15th. Raymond James Financial raised shares of Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research note on Monday, September 15th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Healthpeak Properties in a research note on Monday. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.18.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.